Search Results 291-300 of 16845 for hydroxychloroquine

  1. Estradiol (topical application route) - Mayo Clinic

    Hydroxychloroquine; Insulin Aspart, Recombinant; Lixisenatide; Netupitant; Pixantrone; Valproic Acid. Using this medicine with any of the following medicines ...

  2. Albiglutide (subcutaneous route) - Mayo Clinic

    Grepafloxacin; Hydrochlorothiazide; Hydroflumethiazide; Hydroxychloroquine; Indapamide; Lanreotide Acetate; Levofloxacin; Lomefloxacin; Metolazone; Moxifloxacin ...

  3. Nateglinide (oral route) - Mayo Clinic

    Hydroxychloroquine; Indapamide; Insulin; Insulin Aspart, Recombinant; Insulin Bovine; Insulin Degludec. Show More. Using this medicine with any of the following ...

  4. Olopatadine and mometasone (nasal route) - Mayo Clinic

    Hydroxychloroquine; Insulin Aspart, Recombinant; Lutetium Lu 177 Dotatate; Macimorelin; Nadroparin; Nirmatrelvir; Phenytoin; Pitolisant; Ritonavir; Sargramostim ...

  5. Publications - Thomas G. Osborn, M.D. - Mayo Clinic

    Effect of treatment with methotrexate, hydroxychloroquine, and prednisone on lymphocyte polyamine levels in rheumatoid arthritis: correlation with the ...

  6. Cevimeline (oral route) - Mayo Clinic

    Cevimeline is used to treat the symptoms of dry mouth often experienced by patients with Sjögren's syndrome. It works by causing certain glands in the mouth to ...

  7. Conjugated estrogens and medroxyprogesterone (oral route) - Mayo Clinic

    Hydroxychloroquine; Idelalisib. Show More. Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but ...

  8. Cromolyn (inhalation route) - Mayo Clinic

    Cromolyn will not help an asthma or bronchospasm attack that has already started. Cromolyn may be used alone or with other asthma medicines, such as ...

  9. Dulaglutide (subcutaneous route) - Mayo Clinic

    Hydroxychloroquine; Indapamide; Lanreotide Acetate; Levofloxacin; Lomefloxacin; Metolazone; Moxifloxacin; Norfloxacin; Octreotide Acetate; Ofloxacin ...

  10. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...